Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Murine cytomegalovirus does not cause alopecia areata in these mice.

Immunotherapy can help treat severe alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Lactobacillus acidophilus substances can kill and stop the spread of cervical cancer cells.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Some gonadal hormone drugs can block filovirus entry into cells.